Literature DB >> 27412596

Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.

Sheila V Graham1.   

Abstract

The human papillomavirus (HPV) life cycle is tightly linked to differentiation of the infected epithelium. This means that viral proteins must exert control over epithelial gene expression in order to optimize viral production. The HPV E2 protein controls replication, transcription, and viral genome partitioning during the viral infectious life cycle. It consists of a nucleic acid-binding domain and a protein-protein interaction domain separated by a flexible serine and arginine-rich hinge region. Over the last few years, mounting evidence has uncovered an important new role for E2 in viral and cellular RNA processing. This Gem discusses the role of E2 in controlling the epithelial cellular environment and how E2 might act to coordinate late events in the viral replication cycle.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27412596      PMCID: PMC5021420          DOI: 10.1128/JVI.00502-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  The papillomavirus E2 proteins: structure, function, and biology.

Authors:  Rashmi S Hegde
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001-10-25

2.  Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.

Authors:  Noor Gammoh; Helena Sterlinko Grm; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Authors:  Moon Kyoo Jang; D Eric Anderson; Koenraad van Doorslaer; Alison A McBride
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

4.  Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein.

Authors:  Helena Sterlinko Grm; Paola Massimi; Noor Gammoh; Lawrence Banks
Journal:  Oncogene       Date:  2005-08-04       Impact factor: 9.867

Review 5.  Evolution of SR protein and hnRNP splicing regulatory factors.

Authors:  Anke Busch; Klemens J Hertel
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-09-02       Impact factor: 9.957

6.  Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.

Authors:  Vandana Sekhar; Shawna C Reed; Alison A McBride
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 7.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

8.  Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.

Authors:  Elaine J Gauson; Brad Windle; Mary M Donaldson; Maria M Caffarel; Edward S Dornan; Nicholas Coleman; Pawel Herzyk; Scott C Henderson; Xu Wang; Iain M Morgan
Journal:  Virology       Date:  2014-08-16       Impact factor: 3.616

Review 9.  HPV Carcinomas in Immunocompromised Patients.

Authors:  Nicole M Reusser; Christopher Downing; Jacqueline Guidry; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-01-29       Impact factor: 4.241

10.  The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.

Authors:  Abida Siddiqa; Karen Campos Léon; Claire D James; Muhammad Faraz Bhatti; Sally Roberts; Joanna L Parish
Journal:  J Gen Virol       Date:  2015-04-24       Impact factor: 3.891

View more
  20 in total

Review 1.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

Review 2.  Control of Viral Latency by Episome Maintenance Proteins.

Authors:  Alessandra De Leo; Abram Calderon; Paul M Lieberman
Journal:  Trends Microbiol       Date:  2019-10-14       Impact factor: 17.079

3.  Analysis of human papilloma virus type 52 integration status in exfoliated cervical cells.

Authors:  Ke Zhang; Zhanjun Liu; Ji Li; Juan Li; Jianghong Yan; Yunchuan Su; Shuying Li; Jintao Li
Journal:  Exp Ther Med       Date:  2017-10-11       Impact factor: 2.447

Review 4.  Mitochondrial Proteins Coded by Human Tumor Viruses.

Authors:  Ilaria Cavallari; Gloria Scattolin; Micol Silic-Benussi; Vittoria Raimondi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

Review 5.  Splicing and Polyadenylation of Human Papillomavirus Type 16 mRNAs.

Authors:  Chengjun Wu; Naoko Kajitani; Stefan Schwartz
Journal:  Int J Mol Sci       Date:  2017-02-09       Impact factor: 5.923

Review 6.  Control of human papillomavirus gene expression by alternative splicing.

Authors:  Sheila V Graham; Arwa Ali A Faizo
Journal:  Virus Res       Date:  2016-11-17       Impact factor: 3.303

7.  hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.

Authors:  Naoko Kajitani; Jacob Glahder; Chengjun Wu; Haoran Yu; Kersti Nilsson; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

Review 8.  The Role of RNA Splicing Factors in Cancer: Regulation of Viral and Human Gene Expression in Human Papillomavirus-Related Cervical Cancer.

Authors:  Andrea Cerasuolo; Luigi Buonaguro; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Front Cell Dev Biol       Date:  2020-06-12

9.  The DNA damage response activates HPV16 late gene expression at the level of RNA processing.

Authors:  Kersti Nilsson; Chengjun Wu; Naoko Kajitani; Haoran Yu; Efthymios Tsimtsirakis; Lijing Gong; Ellenor B Winquist; Jacob Glahder; Lars Ekblad; Johan Wennerberg; Stefan Schwartz
Journal:  Nucleic Acids Res       Date:  2018-06-01       Impact factor: 16.971

10.  Differential phosphorylation determines the repressor and activator potencies of GLI1 proteins and their efficiency in modulating the HPV life cycle.

Authors:  Alla Piirsoo; Anne Pink; Lagle Kasak; Martin Kala; Sergo Kasvandik; Mart Ustav; Marko Piirsoo
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.